Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Link to Dutton 01-15-09 PTSC Research Note

The settlement money has never shown up in revenue. You have to look for it in the 10Q as Dutton states, as income from "other investments".

I posted this a over year and a half ago.


Income Statement

posted on Aug 15, 07 11:35AM

This data is off Yahoo and is old. However, I believe they(PTSC) need to foot note their income statement to inform everyone where the money comes from. An investor looking at this information only, as it is, shows very poor revenue quarter over quarter, even though we are bringing in millions from our "other" investments.





Income Statement
Revenue (ttm): 79.69K
Revenue Per Share (ttm): 0
Qtrly Revenue Growth (yoy): -92.00%
Gross Profit (ttm): 10.21M
EBITDA (ttm): 24.63M
Net Income Avl to Common (ttm): 11.51M
Diluted EPS (ttm): 0.028
Qtrly Earnings Growth (yoy): -59.10%
Share
New Message
Please login to post a reply